BridgeBio Pharma (BBIO) News Today $49.08 -1.15 (-2.29%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$49.52 +0.45 (+0.91%) As of 08/22/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period 272,506 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by CW Advisors LLCAugust 24 at 7:09 AM | marketbeat.comAmerican Century Companies Inc. Has $35.52 Million Position in BridgeBio Pharma, Inc. $BBIOAugust 24 at 4:08 AM | marketbeat.com175,000 Shares in BridgeBio Pharma, Inc. $BBIO Bought by Monashee Investment Management LLCAugust 23 at 8:31 AM | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 26,156 SharesAugust 23 at 8:17 AM | insidertrades.comNuveen LLC Buys Shares of 433,112 BridgeBio Pharma, Inc. $BBIOAugust 23 at 4:16 AM | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Stock Price Down 2.1% After Insider SellingAugust 23 at 2:52 AM | americanbankingnews.comBrokerages Set BridgeBio Pharma, Inc. (NASDAQ:BBIO) Price Target at $61.35August 22 at 2:31 AM | americanbankingnews.comBridgeBio Pharma (NASDAQ:BBIO) CFO Sells $871,641.19 in StockAugust 21 at 9:02 PM | marketbeat.comThomas Trimarchi Sells 17,353 Shares of BridgeBio Pharma (NASDAQ:BBIO) StockAugust 20, 2025 | insidertrades.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Average Recommendation of "Buy" from BrokeragesAugust 20, 2025 | marketbeat.comTD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO) on Strong Attruby SalesAugust 20, 2025 | msn.comDruckenmiller's Duquesne adds Warner Bros., exits BridgeBio among Q2 tradesAugust 19, 2025 | msn.comBridgeBio Pharma: Betting Big On Rare Disease CatalystsAugust 19, 2025 | seekingalpha.comCharles Schwab Investment Management Inc. Sells 24,536 Shares of BridgeBio Pharma, Inc. $BBIOAugust 19, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Is Expected To Breakeven In The Near FutureAugust 18, 2025 | finance.yahoo.comInvesco Ltd. Has $76.27 Million Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Makes New Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 18, 2025 | marketbeat.comVanguard Group Inc. Cuts Stock Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 16, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Hits New 1-Year High - Here's What HappenedAugust 15, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Charles J. Homcy Sells 50,000 SharesAugust 14, 2025 | marketbeat.comCharles J. Homcy Sells 250,000 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockAugust 14, 2025 | marketbeat.comInformed Momentum Co LLC Takes $3.92 Million Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 13, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells $2,400,000.00 in StockAugust 13, 2025 | insidertrades.comLeerink Partners Remains a Buy on BridgeBio Pharma (BBIO)August 12, 2025 | theglobeandmail.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) CAO Maricel Apuli Sells 1,000 SharesAugust 12, 2025 | marketbeat.comInsider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CEO Sells 40,000 Shares of StockAugust 12, 2025 | marketbeat.comInsider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CAO Sells 1,000 Shares of StockAugust 12, 2025 | insidertrades.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Cary Street Partners Financial LLCAugust 11, 2025 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)August 11, 2025 | theglobeandmail.comBridgeBio Pharma (BBIO) Receives a Buy from Truist FinancialAugust 11, 2025 | theglobeandmail.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Covestor LtdAugust 10, 2025 | marketbeat.comCetera Investment Advisers Has $1.78 Million Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 10, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Upgraded to "Hold" at Wall Street ZenAugust 10, 2025 | marketbeat.comCantor Fitzgerald Has Positive View of BBIO FY2025 EarningsAugust 9, 2025 | marketbeat.comLeerink Partnrs Predicts Lower Earnings for BridgeBio PharmaAugust 9, 2025 | marketbeat.comBridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | seekingalpha.comCommerce Bank Invests $209,000 in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 9, 2025 | marketbeat.comInsider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells 17,167 Shares of StockAugust 8, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $57.00 at ScotiabankAugust 7, 2025 | marketbeat.comTraders Purchase High Volume of Put Options on BridgeBio Pharma (NASDAQ:BBIO)August 7, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Shares Gap Down Following Weak EarningsAugust 7, 2025 | marketbeat.comOppenheimer Increases BridgeBio Pharma (NASDAQ:BBIO) Price Target to $61.00August 7, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Mackenzie Financial CorpAugust 7, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Posts Quarterly Earnings Results, Misses Estimates By $0.45 EPSAugust 6, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Hits New 52-Week High - Should You Buy?August 6, 2025 | marketbeat.comBridgeBio Reports Second Quarter 2025 Financial Results and Business UpdatesAugust 5, 2025 | globenewswire.comBridgeBio Pharma Q2 2025 Earnings PreviewAugust 5, 2025 | msn.comBridgeBio Pharma Inc (BBIO) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 4, 2025 | finance.yahoo.comBIT Capital GmbH Purchases 282,731 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 4, 2025 | marketbeat.comAllianz Asset Management GmbH Takes Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 4, 2025 | marketbeat.com Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address BBIO Media Mentions By Week BBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBIO News Sentiment▼0.760.71▲Average Medical News Sentiment BBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBIO Articles This Week▼2010▲BBIO Articles Average Week Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BeOne Medicines News BioNTech News Insmed News Teva Pharmaceutical Industries News Summit Therapeutics News Genmab A/S News Viatris News Ascendis Pharma A/S News Dr. Reddy's Laboratories News QIAGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBIO) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access